WELCOME TO ONCOSCIENCE

About Us

Oncoscience GmbH develops therapeutic options for rare diseases in oncology.

CLICK HERE FOR MORE INFO


ONCOLOGY

Oncology and Orphan Drugs

Cancer is one of the leading causes of death worldwide and e.g. in Germany the second leading cause of death after cardiovascular diseases.

CLICK HERE FOR MORE INFO

NEWS

Publication shows benefit in patients with locally advanced or metastatic pancreatic cancer treated with nimotuzumab in combination with gemcitabine.

Oncoscience | November 17th, 2017

The findings from a randomized a Phase IIb/IIIa study combining nimotuzumab with gemcitabine in 192 patients with locall...

legal form changed

Oncoscience | August 22nd, 2017

We are now Oncoscience GmbH. Managing directors are Dr. Dirk Reuter, Dr. Budhi Simon and Robert Ellerson....

Oncoscience AG attends the Nimotuzumab Global Scientific Meeting, 7th-10th April 2016 in Varadero/ Cuba

Oncoscience | April 7th, 2016

At this global clinical development meeting, more than 150 researches from over 20 countries discuss the latest results ...